Integrative gene network analysis provides novel regulatory relationships, genetic contributions and susceptible targets in autism spectrum disorders

Gene

Volumn 496, Issue 2, 2012, Pages 88-96

  Lee, Tin Lap ^a,b   Raygada, Margarita J ^a   Rennert, Owen M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Autism; CNV; Genetics; Genomics; Systems biology

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR; EPIDERMAL GROWTH FACTOR; ESTRADIOL; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; NEU DIFFERENTIATION FACTOR; OXYTOCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SEROTONIN TRANSPORTER; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR;

ARTICLE; AUTISM; BRAIN CELL; CELL ACTIVATION; CENTRIC NODE NETWORK; CHROMOSOME DUPLICATION; CLINICAL FEATURE; COPY NUMBER VARIATION; EVIDENCE BASED PRACTICE; GENE DELETION; GENE EXPRESSION SYSTEM; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC ENGINEERING; GENETIC SUSCEPTIBILITY; GENETICS; NERVE CELL GROWTH; NEUROTRANSMISSION; PHENOTYPE; PRIORITY JOURNAL; SOCIAL BEHAVIOR;

EID: 84862802247     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.01.020     Document Type: Article

References (36)

1. Bailey A., Phillips W., Rutter M. Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J. Child Psychol. Psychiatry 1996, 37:89-126.
2. Bryson S.E., Rogers S.J., Fombonne E. Autism spectrum disorders: early detection, intervention, education, and psychopharmacological management. Can. J. Psychiatry 2003, 48:506-516.
3. Carbon S., Ireland A., Mungall C.J., Shu S., Marshall B., Lewis S. AmiGO: online access to ontology and annotation data. Bioinformatics 2009, 25:288-289.
4. Charman T., Baird G. Practitioner review: diagnosis of autism spectrum disorder in 2- and 3-year-old children. J. Child Psychol. Psychiatry 2002, 43:289-305.
5. Collaer M.L., Hines M. Human behavioral sex differences: a role for gonadal hormones during early development?. Psychol. Bull. 1995, 118:55-107.
6. Coutinho A.M., Oliveira G., Morgadinho T., Fesel C., Macedo T.R., Bento C., et al. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol. Psychiatry 2004, 9:264-271.
7. Crespi B., Badcock C. Psychosis and autism as diametrical disorders of the social brain. Behav. Brain Sci. 2008, 31:241-261.
8. Cusco I., Medrano A., Gener B., Vilardell M., Gallastegui F., Villa O., et al. Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder. Hum. Mol. Genet. 2009, 18:1795-1804.
9. Dwyer N.D., Winckler B. TGF-β receptors PAR-ticipate in axon formation. Cell 2010, 142:21-23.
10. Enstrom A., Lit L., Onore C., Gregg J., Hansen R., Pessah I., et al. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 2009, 23:124-133.
11. Fombonne E. The prevalence of autism. JAMA 2003, 289:87-89.
12. Geschwind D.H. Advances in autism. Annu. Rev. Med. 2009, 60:367-380.
13. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
14. Hu V.W., Nguyen A., Kim K.S., Steinberg M.E., Sarachana T., Scully M.A., et al. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One 2009, 4:e5775.
15. Hu V.W., Sarachana T., Kim K.S., Nguyen A., Kulkarni S., Steinberg M.E., et al. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2009, 2:78-97.
16. Kanner L. Autistic disturbances of affective contact. Nerv. Child 1943, 2:217-250.
17. Kumar R.A., Christian S.L. Genetics of autism spectrum disorders. Curr. Neurol. Neurosci. Rep. 2009, 9:188-197.
18. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., et al. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207:111-116.
19. Lord C., Leventhal B.L., Cook E.H. Quantifying the phenotype in autism spectrum disorders. Am. J. Med. Genet. 2001, 105:36-38.
20. Ma D., Salyakina D., Jaworski J.M., Konidari I., Whitehead P.L., Andersen A.N., et al. A genome-wide association study of autism reveals a common novel risk locus at 5p14.1. Ann. Hum. Genet. 2009, 73:263-273.
21. Malone R.P., Gratz S.S., Delaney M.A., Hyman S.B. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders. CNS Drugs 2005, 19:923-934.
22. Merico D., Isserlin R., Stueker O., Emili A., Bader G.D. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 2010, 5:e13984.
23. Merikangas A.K., Corvin A.P., Gallagher L. Copy-number variants in neurodevelopmental disorders: promises and challenges. Trends Genet. 2009, 25:536-544.
24. Pardo C.A., Vargas D.L., Zimmerman A.W. Immunity, neuroglia and neuroinflammation in autism. Int. Rev. Psychiatry 2005, 17:485-495.
25. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
26. Posey D.J., Erickson C.A., McDougle C.J. Developing drugs for core social and communication impairment in autism. Child Adolesc. Psychiatr. Clin. N. Am. 2008, 17:787-801. viii-ix.
27. Ronald A., Butcher L.M., Docherty S., Davis O.S., Schalkwyk L.C., Craig I.W., et al. A genome-wide association study of social and non-social autistic-like traits in the general population using pooled DNA, 500 K SNP microarrays and both community and diagnosed autism replication samples. Behav. Genet. 2010, 40:31-45.
28. Schonweiler R., Ptok M., Radu H.J. A cross-sectional study of speech- and language-abilities of children with normal hearing, mild fluctuating conductive hearing loss, or moderate to profound sensoneurinal hearing loss. Int. J. Pediatr. Otorhinolaryngol. 1998, 44:251-258.
29. Serajee F.J., Zhong H., Nabi R., Huq A.H. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J. Med. Genet. 2003, 40:e42.
30. Veenstra-Vanderweele J., Christian S.L., Cook E.H. Autism as a paradigmatic complex genetic disorder. Annu. Rev. Genomics Hum. Genet. 2004, 5:379-405.
31. Vismara L.A., Rogers S.J. Behavioral treatments in autism spectrum disorder: what do we know?. Annu. Rev. Clin. Psychol. 2010, 6:447-468.
32. Walker S.J., Segal J., Aschner M. Cultured lymphocytes from autistic children and non-autistic siblings up-regulate heat shock protein RNA in response to thimerosal challenge. Neurotoxicology 2006, 27:685-692.
33. Wall D.P., Esteban F.J., Deluca T.F., Huyck M., Monaghan T., Velez de Mendizabal N., et al. Comparative analysis of neurological disorders focuses genome-wide search for autism genes. Genomics 2009, 93:120-129.
34. Wang K., Zhang H., Ma D., Bucan M., Glessner J.T., Abrahams B.S., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
35. Weiss L.A., Arking D.E., Daly M.J., Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009, 461:802-808.
36. Yu W., Wulf A., Yesupriya A., Clyne M., Khoury M.J., Gwinn M. HuGE Watch: tracking trends and patterns of published studies of genetic association and human genome epidemiology in near-real time. Eur. J. Hum. Genet. 2008, 16:1155-1158.